Angiogenesis is important in the pathophysiology of endometriosis, a condition characterized by implantation of ectopic endometrium in the peritoneal cavity. Vascular endothelial growth factor (VEGF) is a potent angiogenic factor involved in physiological and pathological angiogenesis, and elevated levels of VEGF are found in peritoneal fluid of patients with endometriosis. Our aim was to investigate the site of expression and regulation of VEGF in endometriosis. VEGF immunoreactivity was found in tissue macrophages present in ectopic endometrium and in activated peritoneal fluid macrophages. Macrophage activation was highest in women with endometriosis, and media conditioned by peritoneal fluid macrophages from these women caused a VEGF-dependent increase in endothelial cell proliferation above that seen from normal women. Peritoneal fluid macrophages secreted VEGF in response to ovarian steroids, and this secretion was enhanced after activation with lipopolysaccharide. Peritoneal fluid macrophages expressed receptors for steroid hormones. VEGF receptors flt and KDR (kinase domain receptor) were also detected, suggesting autocrine regulation. During the menstrual cycle, expression of flt was constant but that of KDR was increased in the luteal phase, at which time the cells migrated in response to VEGF. KDR expression and the migratory response were significantly higher in patients with endometriosis. This study demonstrates that activated macrophages are a major source of VEGF in endometriosis and that this expression is regulated directly by ovarian steroids. ( J. Clin. Invest. 1996. 98:482-489.)
In diabetes mellitus the progression of atherosclerosis is accelerated. The interaction of glucose with atherogenic lipoproteins may be relevant to the mechanisms responsible for this vascular damage. The aim of this study was to examine the effect of glucose-modified low density lipoprotein (LDL) on human monocyte chemotaxis and to investigate the roles of oxidation and glycation in the generation of chemotactic LDL. Cu(II)-mediated LDL oxidation was potentiated by glucose in a dose-dependent manner and increased its chemotactic activity. Incubation with glucose alone, under conditions where very little oxidation was observed, also increased the chemotactic property of LDL. Neither diethylenetriamine pentaacetic acid (DETAPAC) nor aminoguanidine, which both inhibited LDL oxidation, completely inhibited the chemotactic activity of glycated oxidised LDL. The results suggest that both oxidation and glycation contribute to increased chemotactic activity.
Exposure of mammalian cells to oxygen radicals formed by the reduction of molecular oxygen may result in cell dysfunction and death. In endothelial cells, one of the earliest and most consistent features of oxidant attack is a dramatic depletion in intracellular ATP content. The mechanisms involved in this depletion include inhibition of ADP phosphorylation, inactivation of the glycolytic pathway and activation of poly (ADP-ribose) polymerase due to DNA damage which leads to a consumption of NAD and culminates in a decrease in ATP levels [1,2]. Depletion of ATP, by whichever pathway, will ultimately lead to a perturbation in cellular energy requiring processes. Effective treatment against oxidant damage, in addition to protecting cellular targets from attack, must be able to preserve cellular function. Maintenance of cellular ATP levels may be a good indicator of antioxidant efficacy, however, numerous reports [3,4] have demonstrated that depletion of ATP in itself, is not sufficient to cause cell death and also agents which do not maintain ATP levels have been shown to prevent cell death [ 31.In this study we investigated the relationship between early ATP depletion and eventual cell death in human endothelial cells. The ability of various agents to preserve both ATP levels and cell viability, in response to hydrogen peroxide (H2@), over a short treatment time was compared with their ability to sustain these effects over a longer 'recovery' period. The agents used included catalase, the classic H202 scavenger, dimethylthiourea (DMTU) which scavenges both the hydroxyl radical ('OH) and H2Q, phenanthroline, an iron chelator, and 3-aminobenzamide (3-AB), an inhibitor of p l y (ADP-ribose) polymerase.Human endothelial cells were isolated and cultured as previously described [S]. Confluent cell monolayers were washed with a Hank's balanced salt solution containing 0.5% bovine serum albumin (HBSS + A) and treated with H2@ * scavenger in lml of HBSS + A. After a 5h exposure, HBSS + A was replaced with complete growth media and cells were incubated for a further 24h. ATP was determined by a lucin-luciferase assay [6] and cell viability by the lactate dehydrogenase (LD) leakage assay [7].After a 5h exposure, H2@ caused a depletion in ATP levels to 5% of control values (Fig 1). Catalase and DMTU completely prevented this depletion (Fig 1) with a concommitant prevention of cell lysis (results not shown).Similar effects were observed with 3-AB. In contrast, phenanthroline prevented cell lysis but only partially preserved ATP ( 40% of control values). After 24h, no recovery of ATP was observed in cells exposed to H2& alone. Catalase and DMTU treatment maintained ATP content and viability at control levels. In contrast, the short term protective effects of 3-AB were not sustained. Cells treated with phenanthroline did however recover ATP to control levels after 24h.The different effects of the agents examined illustrates the number of pathways involved in oxidant induced ATP depletion. Scavenging of H2@ completely abolished A...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.